CTRI/2017/12/011037
Not yet recruiting
未知
Comparitive study between insulin bolus regimen and glucose insulin infusion regimen on effectiveness of intraoperative blood glucose control - a prospective, randomized controlled study.
Dr Arun P0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Arun P
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Type 2 diabetes mellitus
- •Preoperative fasting blood glucose value \>150mg/dl
- •Surgery duration of \>\= 1hour
Exclusion Criteria
- •Patients with a history of cardiac, respiratory, renal or hepatic failure
- •Patients undergoing cardiac surgery
- •Patients having active infection
- •Patients on steroid therapy
- •Pregnant female
- •Patients with serum potassium below the reference range ( \<3\.5 mmol/L)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of two regimens of Insulin and Insulin-Metformin in glycemic control of type 2 Diabetic patients after CABG surgeryType 2 diabetes.Non-insulin dependent diabetesIRCT201008084365N5Mazandaran University of Medical Sciences100
Completed
Not Applicable
Evaluation of two insulin regimens for control of glucocorticoid induced hyperglycemia during chemotherapyGlucocorticoid induced hyperglycemiaHigh blood glucose caused by anti-inflammatory medication1001842410027655NL-OMON41445Slotervaartziekenhuis26
Recruiting
Phase 3
Investigating the effect of Gliclazide-MR on glycaemic control in type 2 diabetic patientsIRCT20230910059395N1Oroumia University of Medical Sciences90
Recruiting
Phase 3
Effect of synbiotic in treatment of diabetesIRCT20220313054269N1Islamic Azad University, Science and Research Branch76
Completed
Not Applicable
Comparison of the effects of insulin monotherapy and combination therapy with ipragliflozin and insulin on glucose toxicity in type 2 diabetes mellitus : a randomized controlled trialType 2 diabetesJPRN-UMIN000018784Osaka university medical hospital40